Breaking News, Promotions & Moves

Vistagen Names Nick Tressler as Chief Financial Officer

Tressler brings over 20 years of experience having served at Dynex Technologies, Senseonics, Sucampo, and MedImmune.

By: Rachel Klemovitch

Assistant Editor

Vistagen, a late clinical-stage biopharmaceutical company, appointed Nick Tressler as Chief Financial Officer (CFO), effective December 1, 2025. Tressler brings over 20 years of financial leadership experience in the life sciences industry, guiding companies through pivotal growth and transformation.  Most recently, he served as CFO of Dynex Technologies, and before that, he was the CFO at American Gene Technologies, International, and Senseonics Holdings, Inc. Tressler has also he...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters